NCT06784505

Brief Summary

To determine obstetric outcomes in primigravida at term at women's health centre

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

January 10, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 20, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

January 20, 2025

Status Verified

January 1, 2025

Enrollment Period

1 year

First QC Date

January 10, 2025

Last Update Submit

January 14, 2025

Conditions

Keywords

Primigravidae

Outcome Measures

Primary Outcomes (1)

  • Maternal outcome

    Maternal outcome woth respect to course of labour \& duration of first and second stage of labour

    10 hours

Secondary Outcomes (1)

  • Progress of labour & neonatal outcome

    10 hours

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primigravida in labor satisfying the inclusion criteria

You may qualify if:

  • Primigravida with singleton live fetus
  • Cephalic presentation
  • Delivered at term with gestational age(37 -41 weeks)

You may not qualify if:

  • Multiparous women
  • Multiple gestation
  • Intra Uterine fetal death th (IUFD)
  • Medical condition as preclampsia
  • Polyhydramnios and fetal anomalies
  • Malpresentation (e.g., breech, face).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

Central Study Contacts

Professor Ahmed Abbas

CONTACT

Menna Abdelaziz Ahmed, Resident

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

January 10, 2025

First Posted

January 20, 2025

Study Start

January 1, 2025

Primary Completion

January 1, 2026

Study Completion

February 1, 2026

Last Updated

January 20, 2025

Record last verified: 2025-01